In spite of the growing knowledge obtained about immune control of Trypanosoma …

• Abstract
• Dynamics of Immune Response Early in T.Cruzi Infection
• Relative roles of T cells and antibodies in adaptive immunity
• The Class I MHC pathway of antigen presentation in T. Cruzi infected cells
• T. cruzi clonal diversity and amastigote evasion mechanisms
• Dual role of trypomastigote-specific killer T cells
• Abortive cycles of amastigote replication: role of class I MHC killer T cells
• T. cruzi proteases as factors of virulence and pathogenicity
• Role of CD8+ Killers in th exacerbation of chronic immunopathology
• References

Biology Articles » Parasitology » A Role for Extracellular Amastigotes in the Immunopathology of Chagas Disease » References

References

- A Role for Extracellular Amastigotes in the Immunopathology of Chagas Disease

• Affranchino JL, Ibanez CF, Luquetti AO, Rassi A, Reyses MB, Macina RA, Aslund L, Pettersson U, Frash ACC 1989. Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas' disease. Mol Biochem Parasitol 34: 221-228.   
• Aliberti JC, Cardoso MA, Martins GA, Gazzinelli RT, Vieira LQ, Silva JS 1996. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect Immun 64: 1961-1967.   
• Andrade SG, Andrade Z 1966. Estudo histopatologico comparativo das lesões produzidas por 2 cepas do Trypanosoma cruzi. O Hospital 70: 1268-1278.   
• Andrade ZA, Andrade SG, Correa R, Sadigursky M, Ferrans VJ 1994. Myocardial changes in acute Trypanosoma cruzi infection: ultrastructural evidence of immune damage and the role of microangiopathy. Am J Pathol 144: 1403-1411.   
• Andrade ZA, Andrade SG, Sadigursky M, Wenthold RJ Jr, Hilbert SL, Ferrans VJ 1997. The indeterminate phase of Chagas' disease: ultrastructural characterization of cardiac changes in the canine model. Am J Trop Med Hyg 57: 328-336.   
• Andrade ZA, Zhang YuZX, Andrade SG, Takeda K, Sadigursky M, Ferrans VJ 1999. Apoptosis in a canine model of acute Chagasic myocarditis. J Mol Cell Cardiol 581-596. 
• Andrade LO, Machado CMS, Chiari E, Pena SDJ, Macedo AM 1999. Role of parasite and host genetic backgrounds in the differential tissue tropism of Trypanosoma cruzi strains (this volume).
• Arnholdt AC, Piuvezam MR, Russo DM, Lima AP, Pedrosa RC, Reed SG, Scharfstein J 1993. Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase. J Immunol 15: 3171-3179. 
• Bahia-Oliveira LM, Gomes JA, Rocha MO, Moreira MC, Lemos EM, Luz ZM, Pereira ME, Coffman RL, Dias JC, Concado JR, Gazzinelli G, Correa-Oliveira R 1998. IFN-gamma in human Chagas' disease: protection or pathology? Braz J Med Res 31: 127-131. 
• Barret AJ, Rhawlings ND, Davies ME, Machleidt W, Salvesen G, Turk V 1986. In AJ Barret & G Salvesen (eds), Proteinase inhibitors: cysteine-proteinase inhibitors of the cystatin superfamily, p. 515-569. Elsevier, Amsterdam.
• Bhoola KD, Figueroa CD, Worthy K 1992. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 44: 1-80.
• Bockmann S, Paegelow I 1995. Bradykinin receptors and signal transduction pathways in peritoneal guinea pig macrophages. Eur J Pharmacol 291: 159-165.
• Bockmann S, Mohrdieck K, Schmidt H, Zundorf G, Paegelow I 1998. Differential sensitivity of macrophages to bradykinin. Naunyn-Schmiedeberg's Arch Phamarcol 357: 151-158. 
• Brener 1965. Comparative studies of different strains of Trypanosoma cruzi. Ann Trop Med Parasitol 59: 19-26.
• Burch RM, Kyle D 1992. Recent developments in the understanding of bradykinin receptors. Life Sci 50: 829-838.
• Burleigh B, Andrews NW 1998. Signaling and host cell invasion by Trypanosoma cruzi. Curr Opin Microbiol 1: 461-465. 
• Camargo MM, Almeida IC, Pereira ME, Ferguson MA, Travassos LR, Gazinelli RT 1997. Glycosylphos-phatidylinsitol-anchored micin-like glycoproteins isolated from Trypanosoma cruzi trypomastigote initiate the synthesis of proinflammatory cttokines by macrophages. J Immunol 158: 5890-5901.
• Cazzulo J, Cousi R, Raimondi A, Wernstedt C, Hellman U 1989. Further characterization and partial amino acid sequence of a cysteine protease (cruzipain) from Trypanosoma cruzi. Mol Biochem Parasitol 33: 33-42.
• Campetella O, Henrickson J, Aslund L, Frasch ACC, Petterson U, Cazzulo JJ 1992. The major cysteine protease (cruzipain) is encoded by multiple polymorphic tandemly repeated organuzed genes located in different chromossomes. Mol Biochem Parasitol 50: 225-234.
• Cardillo F, Voltarelli, JC, Reed SG, Silva JS 1996. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect Immun 64: 128-134. 
• Cerwenka A, Carter LL, Reome, JB, Swain, SL, Dutton RW. 1998. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J Immunol 161: 97-105.
• Colli W 1993. Trans-sialidase: a unique enzyme activity discovered in the protozoan Trypanosoma cruzi. FASEB J 7: 1257-1264.
• Cotta de Almeida V, Bertho AL, Villa verde DM, Savino W 1997. Phenotypic and functional alteration of thymic nurse cells following acute T. cruzi infection. Clin Immunopath 82: 125-132.
• Coutinho CMLM, Cavalcanti, GH, van Leuven, Araujo-Jprge, TC. 1997. Alpha-2 Macroglobulin binds to the surface of Trypanosoma cruzi. Parasitol Res 83:144-150.
• Cunha-Neto E, Coelho V, Guilherme A, Fiorelli N, Stolf N, Kalil J 1996. Autoimmunity in Chagas' disease-identification of cardiac myosin-B13 Trypanosoma cruzi protein cross-reactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J Clin Inv 98: 1709-1712.
• de Diego JA, Palau MT, Gamallo C, Penin P 1998. Relationships between histopathological findings and phylogenetic divergence in Trypanosoma cruzi. Trop Med Int Health 3: 222-233.
• Del Nery E, Juliano MA, Lima APCA, Scharfstein J, Juliano L 1997. Kininogenase activity by major cysteinyl proteinase (Cruzipain) from Trypanosoma cruzi. J Biol Chem 272: 25713-25718.
• D' Imperio Lima MR, Joskowicz M, Coutinho A, Kipnis T, Eisen H 1985. Very large and isotypically atypical polyclonal plaque-forming cell responses en mice infected with Trypanosoma cruzi. Eur J Immunol 15: 201.  
• Dos Reis GA 1997. Cell-mediated immunity in experimental Trypanosoma cruzi infection. Parasitol Today 13: 335-341.
• Dvorak JA, Hyde TP 1973. Trypanosoma cruzi: interaction with vertebrate cells in vitro. Individual interactions at the cellular and subcellular levels. Experim Parasitol 34: 268-283.
• Eakin AE, Mills AA, Harth G, McKerrow JH, Craik CS 1992. The sequence, organization and expresion of the major cysteine protease (cruzain) from Trypanosoma cruzi. J Biol Chem 267: 7411-7420.
• Gazzinelli RT, Leme VCM, Cançado JR, Gazzinelli G, Scharfstein J 1990. Identification and partial characterization of T. cruzi antigens recognized by T cells and immune sera from chagasic patients. Infec Immuni 58: 1437-1444.
• Gazzinelli RT, Oswald IP, James SL, Sher A 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J Immunol 148: 1792-1796.
• Gillat D, Cahalon L, Hershkoviz R, Lider O 1996. Interplay of T cells and cytokines in the context of enymatically modified extracellular matrix. Immunol Today 17: 16-20.  
• Giordano R, Chammas R, Veiga SS, Colli W, Alves MJ 1994. An acidic component of the heterogeneous Tc-85 protein family from the surface of Trypanosoma cruzi is a laminin binding glycoprotein. Mol Biochem Parasitol 65: 85-94.
• Higuchi ML, De Brito T, Reis MM, Barbosa A, Bellotti G, Pereira Barreto AC, Pileggi F 1993. Correlation between Trypanosoma cruzi parasitism amd myocardial inflammatory infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings. Cardiv Pathol 2: 101-106.
• Higuschi ML, Fukasawa S, De Brito T, Parzianello LC, Bellotti G, Ramires JAF 1999. Different microcirculatory and intestinal matrix patterns in idiopathic dilated cardiomyopathy and Chagas' disease: a three dimensional confocal microscopy study. Heart 81: 1-6.
• Iida K, Whitlow NM, Nussenzweig V 1989. Amastigotes of Trypanosoma cruzi escape destruction by terminal complement components. J Exp Med 169: 881-891.
• Kahn SJ, Wleklinski M 1997. The surface glycoproteins of Trypanosoma cruzi encode a superfamily of variant T cell epitopes. J Immunol 159: 4444-4451.
• Kahn SJ, Wleklinski M,Aruffo A, Farr A, Coder D, Kahn M 1995. Trypanosoma cruzi adhesion to macrophages is facilitated by the mannose receptor. J Exp Med 182:1243-1258.
• Koberle F 1968. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv Parasitol 6: 63-116.
• Kolb H, Kolb-Bachofen V 1998. Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol Today 19: 556-561.
• Krettli AU, Brener Z 1982. Resistance against Trypanosoma cruzi is associated to anti-living trypomas-tigote antibodies. J Immunol 128: 2009-2012
• Kumar S, Tarleton RL 1998. The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi. Parasite Immunol 20: 207-216.
• Lages-Silva E, Ramirez LE, Krettli AU, Brener Z 1987. Effect of protective and non-protective antibodies in the phagocytosis rate of Trypanosoma cruzi blood forms by mouse peritoneal macrophages. Parasite Immunol 9: 21-30.
• Lenzi HL, Oliveira DN, Lima MT, Gattass CR 1996. Trypanosoma cruzi: paninfectivity of CL strain during murine acute infection. Exper Parasitol 84: 16-27.
• Ley V, Andrews NW, Robbins ES, Nussenzweig V 1988. Amastigote of Trypanosoma cruzi sustain na infective cycle in mammalian cells. J Exp Med 168: 649-659.   
• Libby P, Alroy J, Pereira MEA 1986. A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells. J Clin Invest 77: 127-135.
• Lima APCA, Tessier DC, Thomas DY, Scharfstein J, Storer AC, Vernet T 1994. Identification of new cysteine protease gene isoforms in Trypanosoma cruzi. Mol Biochem Parasitol 67: 333.
• Low HP, Santos MAM, Wizel B, Tarleton RL 1997. Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ cytotoxic T lymphocytes. J Immunol (in press).
• Macedo AM, Pena S 1998. Genetic variability of Trypanosoma cruzi: implications for the pathogenesis of Chagas' disease. Parasitol Today 14: 119-124.
• Mariano CR, Dímperio Lima MR, Grisotto MG, Alvarez JM 1999. Influence of acute-phase parasite load pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease. Infect Immun 67: 308-18.
• McKerrow JH, McGrath ME, Engel JC 1995. The cysteine protease of Trypanosoma cruzi as a model for antiparasite drug design. Parasitol Today 11: 279-282.
• Meirelles MN, Juliano L, Carmona E, Silva SG, Costa EM, Murta AC, Scharfstein J 1992. Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro. Mol Biochem Parasitol 52: 175-184.
• Melo RC, Brener Z 1978. Tissue tropism of different Trypanosoma cruzi strains. J Parasitol 64: 475-482.
• Miles MA, Souza A, Povoa M, Shaw JJ, Lainson R, Toye PJ 1978. Isozymic heterogenity of Trypanosoma cruzi in the first autochtonous patients with Chagas' diosease in Amazonian Brazil. Nature 272: 819-821.
• Ming M, Ewen ME, Pereira, MEA. 1995. Trypanosoma invasion of mammalian cells requires activation of the TGFb signaling pathway. Cell 82: 287-296. 
• Mombouli JV, Vanhoutte PM 1995. Kinins and endothelial control of vascular smooth muscle. Annu Rev Pharmacol Toxicol 35: 679-705.
• Morel C, Chiari E, Camargo EP, Mattei DM, Romanha AJ, Simpson L 1980. Strains and clones of Trypanosoma cruzi can be characterized by restriction endonucleases fingerprint of kinetoplast DNA molecules. Proc Natl Acad Sci USA 77: 6810-6814.
• Morrot A, Dudley KS, Higuchi ML, Reis M, Pedrosa R, Scharfstein J 1997. Human T cell response against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi: role of the multifunctional alpha2-macroglobulin receptor in antigen presentation by monocytes. Inter Immunol 9: 825-834.
• Morris SA, Tanowitz H, Wittner M, Bilezikjan JP 1990. Pathophysiological insights the cardiomyopathy of Chagas' disease. Circulation 82: 1900.
• Murta AC, Persechini PM, Padron T de S, de Souza W, Guimaraes JA, Scharfstein J 1990. Structural and functional identification of GP57/51 antigen of Trypanosoma cruzi as a cysteine proteinase. Mol Biochem Parasitol 43: 27-38.
• Munoz-Fernandez M, Fernandez MA, Fresno M 1992. Synergism between tumor necrosis factor-alpha and interferon-gama on macrophage activation for the killing of intra cellular Trypanosoma cruzi throught a nitric oxide-dependent machanism. Eur J Immunol 22: 301-307.
• Pereira ME, Zhang K, Gong Y, Herrera EM, Ming M 1996. Invasive phenotype of Trypanosoma cruzi restricted to a population expressing trans-sialidase. Infect Immun 64: 3884-3892.
• Postan M, Cheever AW, Dvorak JA, McDaniel JP 1996. A histopathological analysis of the course of myocarditis in C3H/He mice infected with Trypanosoma cruzi clone Sylvio-X10/4. Trans R Soc Trop Med Hyg 80: 50-55.
• Procopio DO, Teixeira MM, Camargo M, Travassos LR, Ferguson MA, Almeida IC, Gazzinelli RT 1999. Differential inihibitory mechanism of cyclic AMP on TNF a and IL12 synthesis by macrophages exposed to microbial stimuli. British J Pharmacol (in press).  
• Ready PD, Miles MA 1980. Delimitation of Trypanosoma cruzi zymodemes by numerical taxonomy. Trans R Soc Trop Med Hyg 74: 238-242.
• Regoli D 1980. Kinins. Brit Med Bull 43: 270-280.
• Reis MM, Higuchi ML, Benvenuti LA, Aiello VD, Gutierrez PS, Bellotti G, Pileggi Fulvio 1997. An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosome cruzi antigens. Clin Immunol Immunopathol 83: 165-172.
• Revolo S, Oury B, Laurent J, Barnabe C, Quesney V, Carriere V, Noel S, Tibayrenc M 1998. Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. Exp Parasitol 89: 30-39.
• Ribeiro dos Santos R, Hudson L 1980. Trypanosoma cruzi: binding of parasite antigens to mammalian cell membranes. Clin Exp Immunol 40: 36-41.
• Ribeiro dos Santos R, Rossi MA, Sauss JL, Silva JS, Savino W, Mengel J 1992. Anti-CD4 abrogates rejection aand reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J Exp Med 175: 28-39.
• Romanha AJ, Da Silva Pereira AA, Chiari E, Kilgour V 1979. Isoenzyme pattern of cultured Trypanosoma cruzi: changes after prolonged subculture. Comp Biochem Parasitol 62B: 139-142. 
• Rossi MA 1990. Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease. Am Heart J 120: 233-236. 
• Russo M, Starobinas N, Minoprio P, Coutinho A, Hontebeyrie-Joskowicz M 1988. Parasitic load increases and myocardial inflammation decreases in T. cruzi-infected mice after inactivation of helper T cells. Ann Inst Pasteur/Immunol 139: 225-236.
• Russo M, Starobinas N, Ribeiro dos Santos R, Minoprio P, Hontebeyrie-Joskowicz M 1989. Susceptible mice present higher macrophage activation than resistant mice during infections with myotropic strains of Trypanosoma cruzi. Parasite Immunol 11: 385.
• Salazar NA, Mondragon A, Kelly JM 1996. Mucin-like glycoprotein genes are closely linked to members of the trans-sialidase super-family at multiple sites in the Trypanosoma cruzi genome. Mol Bioch Parasitol 78: 127-136.
• Scharfstein J, Abrahamson M, Souza-Palatnik CB, Barral e Silva A, Silva IV 1995. Antigenicity of cystatin-binding proteins from parasitic protozoan: detection by a proteinase-inhibitor based capture immunoassay (PINC-ELISA). J Immunol Methods 182:63-72.
• Scharfstein J, Rodrigues MM, Alves CA, de Souza W, Previato JO, MendonçaPreviato L 1983. Trypanosoma cruzi: description of a highly purified surface antigen defined by human antibodies. J Immunol 131: 972976.
• Scharfstein J, Schechter M, Senna M, Peralta JM, MendonçaPreviato L, Miles MA 1986. Trypanosoma cruzi: characterization and isolation of a 57/51000 molecular weight surface glycoprotein (GP57/51) expressed by epimatigotes and bloodstream trypomatigotes. J Immunol 137: 1336-1341.
• Schenckman S, Eichinger D, Pereira MEA, Nussenzweig V 1994. Structural and functional properties of Trypanosoma cruzi trans-sialidase. Annu Rev Microbil 48: 499-523. 
• Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, Reed SG 1992. Interleukin 10 and IFN-gama regulation of experimental Trypanosoma cruzi infection. J Exp Med 175: 169-174.
• Stoka V, Nycander M, Lenarcic B, Labriola C, Cazzulo JJ, Bjork I, Turk V 1995. Inhibition of cruzipain, the major cysteine proteinase of the protozoan parasite, Trypanosoma cruzi, by proteinase inhibitors of the cystatin superfamily. FEBS Letters 370: 101-104. 
• Svensjo E, Cyrino FZ, Juliano L, Scharfstein J 1997. Plasma leakage induced in postcapillary venules by the major cysteine-proteinase from Trypanosoma cruzi and its modulation by H1-blocker mepyramine. Microvasc Res 54: 93-97.
• Takle GB, Cross GAM 1991. An 85-kilodalton surface antigen gene family of Trypanosoma cruzi encodes polypeptides homologous to bacterial neuraminidases. Mol Bioch Parasitol 48: 185-198.
• Tarleton RL, Koller BH, Latour A, Postan M 1992. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 26, 356(6367): 338-340.
• Teixeira ARL, Teixeira G, Macedo V, Prata A 1978. Acquired cell-mediated rimmunodepression in acute Chagas' disease. J Clin Inv 62: 1132-1141.
• Teixeira VDPA, Hial V, Gomes RADS, Castro ECC, Reis MG, Rodrigues MLP, Guimarães JV, Rei MA 1997. Correlation between adrenal central vein parasitism and heart fibrosis in chronic chagasic myocarditis. Amer J Trop Med Hyg 56: 177-180.
• Tibayrenc M, Ward P, Moya A, Ayala FJ 1986. Natural population of Trypanosoma cruzi, the agent of Chagas' disease, have a complex multiclonal structure. Proc Natl Acad Sci USA 83: 115-119.
• Tomas AM, Kelly JM 1996. Stage-regulated expression of cruzipain, the major cysteine-proteinase of Trypanosoma cruzi is independent of the level of RNA. Mol Biochem Parasitol 76: 91-103.
• Trischman T, Tanowitz H, Wittner M, Bloom B 1978. Trypanosoma cruzi: role of the immune response in the natural resistance of inbred strains of mice. Exp Parasitol 45: 160-168.
• Wizel B, Nunes M, Tarleton RL 1997. Identification of a Trypanosoma cruzi trans-sialidase family member as a target of protective CD8+ Tc1 responses. J Immunol 159: 6120-6130.
• Wizel B, Palmieri M, Mendoza C, Arana B, Sideney J, Sette A, Tarleton R 1998. Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses. J Clin Invest 102: 1062-1071.
• Zhang L, Tarleton RL 1996. Persistent production of inflammatory and anti- inflammatory cytokines and associated MHC and adhesion molecule expression at the site of infection and disease in experimental Trypanosoma cruzi infections. Exper Parasitol 84: 203-213.